You have 9 free searches left this month | for more free features.

breast cancer chemoprevention postmenopause

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Tumor Trial in New York (RealRisks, BNAV)

Active, not recruiting
  • Breast Neoplasm
  • RealRisks
  • BNAV
  • New York, New York
    Columbia University Medical Center
Aug 16, 2022

Breast Cancer Survivors, Postmenopause, Resistance Training Trial in Temuco (Prolonged resistance-type exercise training)

Not yet recruiting
  • Breast Cancer Survivors
  • +2 more
  • Prolonged resistance-type exercise training
  • Temuco, Chile
    Department of Rehabilitation Sciences, Faculty of Medicine, Univ
Jan 9, 2023

Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ Trial in

Recruiting
  • Atypical Hyperplasia of the Breast
  • +2 more
  • Cancer Educational Materials
  • +3 more
  • Costa Mesa, California
  • +48 more
Jan 9, 2023

Factors Influencing Decision-Making About Use of Chemoprevention

Completed
  • Breast Cancer
  • Counseling session
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 4, 2021

DCIS Trial in Orange (Anastrozole)

Completed
  • DCIS
  • Orange, California
    Chao Family Comprehensive Cancer Center
Apr 19, 2021

Specialist Recommendation on FBC Chemoprevention Prescribing

Unknown status
  • Familial Breast Cancer
  • Survey Administration
  • Nottingham, United Kingdom
    University of Nottingham
Nov 10, 2020

Breast Tumors Trial in New York (RealRisks, BNAV)

Completed
  • Breast Neoplasms
  • RealRisks
  • BNAV
  • New York, New York
    Columbia University Medical Center
Jan 7, 2021

Breast Cancer Trial in Milan (Tamoxifen, Placebo)

Active, not recruiting
  • Breast Cancer
  • Milan, Italy
    European Institute of Oncology
Aug 12, 2021

Breast Cancer Trial in Worldwide (anastrozole, )

Completed
  • Breast Cancer
  • Newcastle, New South Wales, Australia
  • +73 more
Oct 5, 2021

Breast Tumors Trial in Madison (Alendronate)

Terminated
  • Breast Neoplasms
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Oct 20, 2020

Development ofQuantitative Tissue Optical Index of Breast

Withdrawn
  • Accessory; Breast Tissue
  • Breast Density
  • Costa Mesa, California
  • +3 more
Oct 31, 2022

Breast Cancer, Lifestyle Risk Reduction Trial in London Borough of Sutton (Lifestyle intervention to reduce breast cancer risk)

Active, not recruiting
  • Breast Cancer
  • Lifestyle Risk Reduction
  • Lifestyle intervention to reduce breast cancer risk
  • London Borough of Sutton, United Kingdom
    The Royal Marsden Hospital NHS Foundation Trust
Jan 17, 2023

Breast Cancer Trial in New York (RealRisks)

Not yet recruiting
  • Breast Cancer
  • RealRisks
  • New York, New York
    Columbia University Irving Medical Center
Apr 12, 2023

FH-Risk 2.0: Updating Breast Cancer Risk Estimates

Recruiting
  • Breast Cancer Risk
  • Notification of a revised breast cancer risk estimate
  • Manchester, Greater Manchester, United Kingdom
    Manchester University NHS Foundation Trust
Dec 17, 2022

Breast Cancer Trial in Manchester (BC-Predict, NHS Breast Screening Programme)

Completed
  • Breast Cancer
  • BC-Predict
  • NHS Breast Screening Programme
  • Manchester, Greater Manchester, United Kingdom
    Manchester University NHS Foundation Trust
Jan 9, 2023

InheriteD brEast caNcer iTalian regIsTrY A

Recruiting
  • Breast Cancer
    • Aviano, Pordenone, Italy
    • +11 more
    Apr 26, 2023

    Ductal Carcinoma in Situ Trial (Tamoxifen, Exemestane, Letrozole)

    Not yet recruiting
    • Ductal Carcinoma in Situ
    • (no location specified)
    Oct 13, 2023

    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,

    Active, not recruiting
    • BRCA1 Mutation Carrier
    • +8 more
    • soy isoflavones
    • +7 more
    • Los Angeles, California
      University of Southern California
    Nov 11, 2021

    Impact of Dietary Inflammatory Potential on Breast Cancer Risk

    Not yet recruiting
    • Breast Atypical Ductal Hyperplasia
    • +4 more
    • Follow-Up
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 16, 2021

    Solid Organ Transplant Recipients, Skin Cancer Trial in Australia (Sirolimus Topical Cream, Placebo)

    Not yet recruiting
    • Solid Organ Transplant Recipients
    • Skin Cancer
    • Sirolimus Topical Cream
    • Placebo
    • Camperdown, New South Wales, Australia
    • +5 more
    May 8, 2023

    Malaria Trial in Kwara (Standard age based SPAQ administration for SMC)

    Recruiting
    • Malaria
    • Standard age based SPAQ administration for SMC
    • Kwara, Nigeria
      Kwara Sentinell Site
    Jul 31, 2023

    Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Italy, United

    Active, not recruiting
    • Stage 0 Breast Cancer AJCC v6 and v7
    • +6 more
    • Tampa, Florida
    • +4 more
    Dec 15, 2021

    Breast MRI Utilization Among Patients at Elevated Risk

    Active, not recruiting
    • Breast Cancer
    • Self-Report Survey
    • Qualitative Interviews
    • Washington, District of Columbia
    • +1 more
    May 27, 2022

    Breast Cancer, Breast Carcinoma, Breast Tumors Trial in Stockholm (Tamoxifen 20 mg)

    Active, not recruiting
    • Breast Cancer
    • +4 more
    • Tamoxifen 20 mg
    • Stockholm, Sweden
      Karolinska University Hospital
    May 24, 2022

    Colorectal Cancer, Colorectal Adenoma, Colorectal Adenomatous Polyp Trial in Calgary (acetylsalicylic acid delayed release

    Not yet recruiting
    • Colorectal Cancer
    • +2 more
    • acetylsalicylic acid delayed release tablets, 81mg
    • Calgary, Alberta, Canada
      Forzani & Macphail Colon Cancer Screening Centre, University of
    May 27, 2022